Karl Insogna

Director, Yale Bone Center · Yale School of Medicine

Credentials: · · · ·

History

Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $2.6M · Yale University
2023–2028
An Ounce of Prevention: Stopping Menopausal Bone Loss Before It Starts
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $403.5K · Yale University
2021–2023
The Role of Sphingosine Kinases in Bone Anabolism
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $1.5M · Yale University
2016–2021
A Novel SATB2 Mutation Illuminates Bone Anabolism
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $402.9K · Yale University
2014–2017

Examining the Effect of Burosumab on Muscle Function
Principal investigator · Completed · Phase 4
Yale University
2019–2022
Calcitonin for Treating X-linked Hypophosphatemia
Principal investigator · Completed
Yale University
2011–2015
The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women
Principal investigator · Completed · Phase 1, Phase 2
Yale University
2007–2012
The Effect of Protein on Calcium Absorption and Gastric Acid Production
Principal investigator · Completed · Phase 4
Yale University
2005–2008